𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients

✍ Scribed by P. Bruggmann; L. Falcato; S. Dober; B. Helbling; O. Keiser; F. Negro; D. Meili; on behalf of the Swiss Hepatitis C Cohort Study


Book ID
108886165
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
126 KB
Volume
15
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.